Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors.
Shabto JM, Martini DJ, Liu Y, Ravindranathan D, Brown J, Hitron EE, Russler GA, Caulfield S, Kissick H, Alemozaffar M, Ogan K, Harris WB, Master VA, Kucuk O, Carthon BC, Bilen MA.
Shabto JM, et al. Among authors: bilen ma.
Cancer Med. 2020 Apr;9(8):2752-2760. doi: 10.1002/cam4.2932. Epub 2020 Feb 25.
Cancer Med. 2020.
PMID: 32100417
Free PMC article.